Allergan (AGN) News Today → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free AGN Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 27, 2024 | finance.yahoo.com30 Most Miserable Countries in the WorldApril 11, 2024 | finance.yahoo.comAllergan Aesthetics and University Lab Partners Announce the Golden Ticket Pitch Competition to Accelerate Aesthetics Start-UpsApril 5, 2024 | uk.investing.comAllergan Aesthetics Announces the Return of CoolMonth with CoolSculptingMarch 26, 2024 | finance.yahoo.comAllergan Aesthetics Launches "Moving the Needle on Ethics" to Elevate the Conversation Around Ethics in AestheticsFebruary 28, 2024 | finance.yahoo.comDr. Ran Y. Rubinstein Has Been Named Top 500 Allergan Aesthetic 2024February 26, 2024 | marketbeat.com6 reasons to buy Teva Pharmaceuticals stock sooner than later (AGN)Investors seeking a long-term and undervalued pharmaceutical play should take a close look at Teva Pharmaceuticals, and here are six reasons whyJanuary 23, 2024 | in.investing.comPro Research: Wall Street eyes AbbVie's growth and pipeline potentialJanuary 23, 2024 | finance.yahoo.comAllē by Allergan Aesthetics is the Leading Aesthetics Loyalty Rewards Program in the U.S.January 18, 2024 | finance.yahoo.comBodyLase® Med Spa Ends 2023 Among Top 50 Allergan ProvidersJanuary 4, 2024 | reuters.comBotox rival Revance loses bid to dismiss Allergan trade secrets lawsuitDecember 29, 2023 | za.investing.comPro Research: Wall Street explores AbbVie's market dynamicsDecember 26, 2023 | za.investing.comPro Research: wall street dives into abbvie's growth potentialDecember 19, 2023 | finance.yahoo.comDr. Ran Y. Rubinstein: Revolutionizing Aesthetics for 18 Years as an Expert Allergan and Galderma TrainerOctober 24, 2023 | markets.businessinsider.comAllergan Announces Positive Results From Phase 3 Studies Of TrenibotulinumtoxinE In Glabella LinesOctober 19, 2023 | finance.yahoo.comAllergan Aesthetics Supports Breast Cancer Patients and Celebrates Breast Reconstruction Patients Through The Reblossom ProjectOctober 18, 2023 | finance.yahoo.comAllergan Aesthetics and University Lab Partners Announce the Golden Passport Pitch Competition to Accelerate Aesthetics Start-UpsOctober 10, 2023 | msn.comUnlocking Vision Wellness: Allergan’s Media Conclave On World Sight Day Spotlights Eyecare's Crucial Role In Modern WorkplaceSeptember 15, 2023 | thestreet.comAllergan (AGN), Pfizer in Advanced Takeover Talks, Stocks Fall, Jim Cramer Weighs InAugust 2, 2023 | ca.investing.comBausch + Lomb's Saunders doesn't expect more big deals in the near termAugust 2, 2023 | za.investing.comBausch + Lomb posts better than expected Q2 earningsAugust 1, 2023 | finance.yahoo.comAllergan Aesthetics Announces First Ever JUVÉDERM® DayJuly 24, 2023 | thestreet.comWhy Valeant Pharmaceuticals (VRX) Stock Is UpJuly 7, 2023 | thestreet.comCramer -- Why a Pfizer Merger With Allergan Makes SenseJune 9, 2023 | msn.comN.C. to receive $521M in opioid settlements with Teva, Allergan, CVS and WalgreensJune 9, 2023 | msn.comVirginia receives $365.6 million in opioid settlements with Teva, Allergan, CVS, and WalgreensMay 22, 2023 | thestreet.comPfizer (PFE) Stock Sinks, Negotiating Break-Up Fee in Allergan Deal, Jim Cramer's ViewMay 17, 2023 | marketwatch.comBipolar Disorder Therapeutics Market Size, Growth Opportunities, Future Trends and Share with Revenue Forecast 2028April 25, 2023 | marketbeat.comVirios Therapeutics Up 75% on Fibromyalgia Phase 3 Proposal (AGN)Virios Therapeutics Inc. (NASDAQ: VIRI) is a developmental-stage biotechnology company specializing in novel antiviral therapies for treating fibromyalgiaMarch 7, 2023 | thestreet.comBiogen (BIIB) Stock Declines in After-Hours, Allergan Unlikely to Pursue TakeoverJanuary 25, 2023 | marketbeat.comIs the Pain Over for Baudax Bio Investors after a 70% Spike? (AGN)Baudax Bio (NASDAQ: BXRX) shares spiked as much as 70% on its announcement of positive interim phase 2 clinical trials for its pain medicine BX1000.October 19, 2022 | finance.yahoo.comAllergan Aesthetics and Girls Inc. Partner to Bridge the Gender Gap in STEM - Yahoo FinanceOctober 15, 2022 | thetimes.co.ukWomen sue over Allergan breast implants | Ireland | The Sunday Times - The TimesOctober 12, 2022 | finance.yahoo.comAllergan Aesthetics Pledges Diamond Level Sponsorship for 2022 Breast Reconstruction Awareness Day - Yahoo FinanceOctober 11, 2022 | news.yahoo.comNew Paris bakery specializes in allergen-free foods - Yahoo NewsOctober 11, 2022 | benzinga.comOutlook on the Male Hypogonadism Global Market to 2030 - Featuring Allergan, Pfizer, Bayer and Endo Inter - BenzingaOctober 11, 2022 | globenewswire.comOcular Implant Market Report (2022 to 2030) - Johnson and Johnson Services Inc., Carl Zeiss AG, Glaukos Corporation, Morcher GmbH, Allergan Inc. and Hoya Corporation - GlobeNewswireOctober 9, 2022 | bizjournals.comIn Her Own Words: Nicci Levy's ALCHEMY 43 focuses on faces - Bizwomen - The Business JournalsOctober 7, 2022 | finance.yahoo.comAllergan Aesthetics to Present Data from Its Leading Aesthetic Portfolio at the 2022 American Society for Dermatologic Surgery Meeting - Yahoo FinanceOctober 7, 2022 | prnewswire.comAllergan Aesthetics to Present Data from Its Leading Aesthetic Portfolio at the 2022 American Society for Dermatologic Surgery Meeting - PR NewswireOctober 7, 2022 | globenewswire.comGlobal Acne Treatment Market (2022 Edition)– Analysis By Treatment, Treatment Modality, End-Users, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2023-2028) - GlobeNewswireOctober 4, 2022 | finance.yahoo.comThe Global Botulinum Toxin Market size is expected to reach $10.5 billion by 2028, rising at a market growth of 10.8% CAGR during the forecast period - Yahoo FinanceOctober 4, 2022 | businesswire.comGlobal Glaucoma Treatment Market Report 2022: Featuring Pfizer, F. Hoffmann-La Roche, Merck, Allergan & Others - ResearchAndMarkets.com - Business WireOctober 3, 2022 | nasdaq.comCan AbbVie's (ABBV) New Drugs Make up for Lost Humira Sales? - NasdaqOctober 3, 2022 | businesswire.comGlobal Dry Eye Syndrome Therapeutics Market Report to 2029 - Featuring Abbott, AbbVie, Allergan and AstraZeneca Among Others - ResearchAndMarkets.com - Business WireOctober 1, 2022 | thestreet.comHow Far Will AbbVie's Humira Revenue Fall in 2023? - TheStreetSeptember 24, 2022 | nasdaq.comIs AbbVie a Buy? - NasdaqSeptember 23, 2022 | benzinga.comHyaluronic Acid-based Dermal Fillers Global Market Report 2022 - BenzingaSeptember 23, 2022 | prnewswire.comThe Forces of Beauty® Report from The DREAM Initiative® Reveals Demand for New Standards of Beauty and Imagery - PR NewswireSeptember 21, 2022 | businesswire.comEvolus Concludes Certain Royalty Payments; Financial Profile Improves Significantly Starting in the Fourth Quarter of 2022 - Business WireSeptember 16, 2022 | law360.comFCA's 'Creative Lawyering' Defense Divides Full 4th Circ. - Law360 Get Allergan News Delivered to You Automatically Sign up to receive the latest news and ratings for AGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden Nomination CANCELED? (Ad)The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words? I believe I have the terrifying answer right here. AGN Media Mentions By Week AGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGN News Sentiment▼0.000.42▲Average Medical News Sentiment AGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGN Articles This Week▼00▲AGN Articles Average Week Get Allergan News Delivered to You Automatically Sign up to receive the latest news and ratings for AGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Zoetis News Today Bristol-Myers Squibb News Today Royalty Pharma News Today BeiGene News Today BioMarin Pharmaceutical News Today Jazz Pharmaceuticals News Today Glaukos News Today Apellis Pharmaceuticals News Today Bausch Health Companies News Today Akero Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:AGN) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryMissed NVDA? Buy this AI stock NOWChaikin AnalyticsMost important medical advance in 100 yearsThe Oxford Club41 banks launch ‘crypto dollar’Stansberry ResearchDems have chosen Biden replacement?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allergan plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
